Treating Obesity with the HCG Diet Protocol
The Obesity Epidemic and the HCG Diet
Today, you do not need to be a medical professional to notice the obesity epidemic that we are facing. It really has become a world wide health problem. This epidemic of weight gain is a complex dance between genetics, the endocrine system, hormone levels and human behavior. The problem is not simply a premise built upon calories ingested and calories expended.
In my clinical experience, I have seen a direct relationship between the HCG Diet and weight loss. The strength of this relationship came to me as quite a surprise in my first few months of facilitating the program in my practice. The HCG Diet has been a safe, effective and maintainable form of weight loss for my patients.
The Early Research of the HCG Diet
In the early 1950’s a British doctor known as Dr. A.T. Simeon had devoted much of his medical practice and research to learn about obesity, as well as, the effects of HCG on body composition. In his research trials with young boys who had a condition known as Froehlichs disease. This condition is defined as having ravenous hunger, obesity and a female pattern of fat deposits around the hips, buttocks and thighs. They also had gynecomastia and underdeveloped testicles. This was all due to an issue in the anterior pituitary.
In the research study, the treatment consisted of biweekly therapeutic injections of HCG. HCG was known to induce precocious puberty in laboratory models. These patient’s despite having no caloric restriction, noted a reduction in appetite, and as an unanticipated finding, the patients lost significant amounts of weight as well as decrease in hip circumference.
These findings, led Dr. Simeons to see a correlation between HCG and weight loss. In 1954, he conducted his own trials which were published in Lancet, in 1954(1). Several clinical trials have attempted to follow in his footsteps, but only one double blind placebo controlled study has achieved the dramatic results Simeon and his many patients described. In my clinical experience, I have seen significant results of weight loss and weight loss maintenance with most of my adherent patients.
In another research study to look further into using HCG for weight loss, Dr. Simeons randomly assigned a group to receive 125 iu of HCG or placebo via subcutaneous injection 6 days/week for 6 weeks. These patients were also placed on a strict diet. An average weight loss of 18 lbs was reported by these patients. Each day, the research group reported their degree of hunger. The majority of patients reported “no feelings of hunger”.(1) They were also asked to report on their general state of well-being and again the majority reported feeling “good” to “excellent. (2)
THE CORRELATION BETWEEN THE HCG DIET AND WEIGHT LOSS
In my experience the HCG Diet protocol has been a pathway for success for so many of my patients in their journey of weight loss and optimal health. Most all of my patients see significant results in weight loss! They begin to enjoy a clean, healthy diet and become motivated to add exercise into their daily life. Helping patients to combat obesity and turn their bodies, their confidence and their lives around has been a celebration for me!
1. Simeon A.T. The action of chorionic gonadotropin in the obese The Lancet 1954 (6845) 946-947.
2. Ascher W.L. Harper H. The effect of chorionic gonadotropin on weight loss, hunger and feeling of well- being. American Journal of Clinical Nutrition Feb 1973;26 (2) 211-218
3. Tan, Jackie, Loh Keh, Yeo George. Transient hyperthyroidism in women with hyperemesis gravidarum. International Journal of Obstetrics and Gynecology June 2002; 109 (6) 683-688
4. Cole, L Biological functions for the HCG and HCG related molecules. Reproductive Biology and Endocrinology 2010; August 8 (102) doi: 1186/1477-7827-8-102
5. Hotakainer K, Haflund C, Paju A. HCG beta subunit and core fragment in bladder banker: mRNA and protein expression in urine, serum and tissue. European Journal of Urology June 2002; 441 (6) 667-685.
6. Kubiczak M, Walkowiak GP, Nowak E. Human chorionic gonadotropin beta subunit genes CGB1 and CGB2 are transcriptionally active on ovarian cancer. International Journal of Molecular Science 2013 June (6) 12650-12660.
7. Kumar R.T Cachexia. Molecular Endocrinology 1999, 13 851-851-856 8. SEER Training Modules; Tumor Markers. U.S. Department of Health and Human Services, National Institute of Health and the National Cancer Institute, last updated 2015.